Evidence map›Paper›PMID 27483256›Full record

ArticleInternational journal of molecular sciences2016

VEGF and FGF2 Improve Revascularization, Survival, and Oocyte Quality of Cryopreserved, Subcutaneously-Transplanted Mouse Ovarian Tissues.

Sheng-Hsiang Li, Yuh-Ming Hwu, Chung-Hao Lu, Hsiao-Ho Chang, Cheng-En Hsieh, Robert Kuo-Kuang Lee

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Dysregulated cytokine profile associated with biochemical premature ovarian insufficiency.American journal of reproductive immunology (New York, N.Y. : 1989) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sheng-Hsiang LiDepartment of Medical Research, Mackay Memorial Hospital, Tamsui District, New Taipei City 251, Taiwan. lsh@mmh.org.tw.
Yuh-Ming HwuDepartment of Medical Research, Mackay Memorial Hospital, Tamsui District, New Taipei City 251, Taiwan. hwu4416@yahoo.com.tw.
Chung-Hao LuDepartment of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei City 104, Taiwan. d95642001@gmail.com.
Hsiao-Ho ChangDepartment of Medical Research, Mackay Memorial Hospital, Tamsui District, New Taipei City 251, Taiwan. smallriver220@gmail.com.
Cheng-En HsiehDepartment of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei City 104, Taiwan. shitxn@gmail.com.
Robert Kuo-Kuang LeeDepartment of Medical Research, Mackay Memorial Hospital, Tamsui District, New Taipei City 251, Taiwan. mmh40@mmh.org.tw.
Mackay Memorial Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was conducted to investigate the effect of the vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF2) on revascularization, survival, and oocyte quality of cryopreserved, subcutaneously-transplanted mouse ovarian tissue. Autologous subcutaneous transplantation of vitrified-thawed mouse ovarian tissues treated with (experimental group) or without (control group) VEGF and FGF2 was performed. After transplantation to the inguinal region for two or three weeks, graft survival, angiogenesis, follicle development, and oocyte quality were examined after gonadotropin administration. VEGF coupled with FGF2 (VEGF/FGF2) promoted revascularization and significantly increased the survival rate of subcutaneously-transplanted cryopreserved ovarian tissues compared with untreated controls. The two growth factors did not show long-term effects on the ovarian grafts. In contrast to the untreated ovarian grafts, active folliculogenesis was revealed as the number of follicles at various stages and of mature oocytes in antral follicles after gonadotropin administration were remarkably higher in the VEGF/FGF2-treated groups. Although the fertilization rate was similar between the VEGF/FGF2 and control groups, the oocyte quality was much better in the VEGF/FGF2-treated grafts as demonstrated by the higher ratio of blastocyst development. Introducing angiogenic factors, such as VEGF and FGF2, may be a promising strategy to improve revascularization, survival, and oocyte quality of cryopreserved, subcutaneously-transplanted mouse ovarian tissue.

Indexed as

AnimalsBlastocystCell SurvivalCryopreservationEmbryonic DevelopmentEnzyme-Linked Immunosorbent AssayFemaleFertilization in VitroFibroblast Growth Factor 2Immunoenzyme TechniquesMiceNeovascularization, PhysiologicOocytesOvarySubcutaneous TissueTransplantation, AutologousFibroblast Growth Factor 2Vascular Endothelial Growth Factor Aangiogenic factorfertility reservationoocyte qualityovarian cryopreservationovarian transplantation

Identifiers

PMID27483256
PMCPMC5000635
OpenAlexW2499250591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.